Inhaled Iloprost for Severe Pulmonary Hypertension
Horst Olschewski(Sigmund Freud Privatuniversität Wien), Werner Seeger(Justus-Liebig-Universität Gießen), David G. Kiely(Royal Hallamshire Hospital), Marius M. Hoeper(Medizinische Hochschule Hannover), T. W. Higenbottam(Royal Hallamshire Hospital), Sylvia Nikkho(MerLion Pharma (Germany)), Wladimir Popov(University Hospital Zurich), Rudolf Speich(University Hospital Zurich), Paul A. Corris(Newcastle College), Nazzareno Galiè(Azienda USL di Bologna), Marion Delcroix(American Institute of Biological Sciences), Jürgen Behr(Ludwig-Maximilians-Universität München), R Ewert, Hossein Ardeschir Ghofrani(Justus-Liebig-Universität Gießen), Olivier Sitbon(Inserm), Harald Siedentop(Ernst Schering Foundation), Robert Naeije(Erasmus Hospital), Jörg Winkler(University Hospital Leipzig), Gérald Simonneau(Inserm), Miguel Ángel Gómez‐Sánchez(Research Institute Hospital 12 de Octubre), Alessandra Manes(IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola), Andreas Meyer(Kerckhoff Klinik), Lewis J. Rubin(University of California San Diego)
Cited by 1,791
Related Papers
Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline
|American Journal of Respiratory and Critical Care Medicine|2018|4.1k
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
|European Heart Journal|2022|3.6k
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS
|European Heart Journal|2017|3k
ESC Guidelines for the management of grown-up congenital heart disease (new version 2010): The Task Force on the Management of Grown-up Congenital Heart Disease of the European Society of Cardiology (ESC)
|European Heart Journal|2010|2.3k
Clinical classification of pulmonary hypertension
|Journal of the American College of Cardiology|2004|1.9k